The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The FDA and EMA's joint guidance was created to ensure the pharmaceutical industry employs best practices when using AI in ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...
An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...
A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...
In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...
The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback